Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  American Journal of Pathology

• Publication date

  1988-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3258475PMCID PMC1880564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling.

  1987cited by this paper
• A new look at lymphoma immunohistology.

  1987cited by this paper
• Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.

  1987cited by this paper
• A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.

  1987cited by this paper
• The molecules controlling B lymphocytes.

  1987cited by this paper
• A B cell-specific differentiation antigen, CD23, is a receptor for IgE (Fc epsilon R) on lymphocytes.

  1987cited by this paper
• Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE.

  1987cited by this paper
• A new look at lymphoma immunohistology.

  1987cited by this paper
• Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.

  1987cited by this paper
• The activation‐associated antigen 4f2 predicts patient survival in low‐grade b‐cell lymphomas

  1987cited by this paper
• Phenotyping of malignant hematopoietic cells. Analysis of 1200 cases of leukemia-lymphoma.

  1986cited by this paper
• Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor

  1986cited by this paper
• Determination of transferrin receptors on frozen sections of malignant B‐cell lymphomas by immunofluorescence with a monoclonal antibody

  1986cited by this paper
• Lineage promiscuity in hemopoietic differentiation and leukemia.

  1986cited by this paper
• Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching

  1986cited by this paper
• Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.

  1986cited by this paper
• Expression of Tac antigen in B cell lymphomas.

  1986cited by this paper
• B Cell/Leukemia Panel Workshop: Summary and Comments

  1986cited by this paper
• Immunologic classification of leukemia and lymphoma.

  1986cited by this paper
• Lymph node examination. What is an adequate workup

  1985cited by this paper
• HNK-1+ cells in non-Hodgkin's lymphoma: lack of relation with transferrin receptor expression on malignant cells.

  1985cited by this paper
• Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders.

  1985cited by this paper
• Activated human B cells display a functional IL 2 receptor.

  1985cited by this paper
• Lymph node examination. What is an adequate workup?

  1985cited by this paper
• Structural and functional characterization of IL 2 receptors on activated human B cells.

  1985cited by this paper
• Expression of Tac antigen on activated normal human B cells

  1984cited by this paper
• Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

  1984cited by this paper
• Clinical relevance of immunologic phenotype in diffuse large cell lymphoma.

  1984cited by this paper
• Immunologic phenotypes of diffuse, aggressive, non‐Hodgkin's lymphomas. Correlation with clinical features

  1984cited by this paper
• Detection and functional studies of p60-65 (Tac antigen) on activated human B cells

  1984cited by this paper
• Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial.

  1984cited by this paper
• Transferrin receptor and B‐lymphoblast antigen — their relationship to DNA synthesis, histology and survival in B‐cell lymphomas

  1984cited by this paper
• Expression of interleukin 2 receptors on activated human B cells

  1984cited by this paper
• Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

  1984cited by this paper
• Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma.

  1983cited by this paper
• Clinical significance of histologic (Kiel) classification combined with immunologic definition of malignant lymphoma.

  1983cited by this paper
• A new working formulation of non‐Hodgkin's lymphomas a retrospective study of the new NCI classification proposal in comparison to the rappaport and kiel classifications

  1983cited by this paper
• Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.

  1983cited by this paper
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

  1982cited by this paper
• Surface marker and histopathologic correlation with long‐term survival in advanced large‐cell non‐Hodgkin's lymphoma

  1981cited by this paper
• Labeling index as a prognostic marker in non-Hodgkin's lymphomas.

  1981cited by this paper
• Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.

  1980cited by this paper
• Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.

  1979cited by this paper
• Histopathology and Diagnosis of Non-Hodgkin’s Lymphomas

  1978cited by this paper
• Surface characteristics of lymphoma cells in relation to treatment, response and survival.

  1978cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• National

  1896cited by this paper
• National cancer institute sponsored study of classifications of non‐hodgkin's lymphomas. Summary and description of a working formulation for clinical usage

  year unknowncited by this paper

• CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma

  2022cites this paper
• EVALUATION OF CD MARKERS IN LYMPHOMA STEM CELLS BY FLOW CYTOMETRY

  2022cites this paper
• High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma

  2020cites this paper
• Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

  2018influential citation
• CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.

  2015cites this paper
• Impact de CD38 dans la leucémie à tricholeucocytes

  2015influential citation
• Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy

  2009cites this paper
• Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma

  2009cites this paper
• Significant high expression of CD23 in follicular lymphoma of the inguinal region

  2007cites this paper
• Expressionsmuster und prognostische Bedeutung von CD24, p53 und p21 in Lymphomen

  2004cites this paper
• [Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas].

  2004cites this paper
• CD21S antigen expression in tumour cells of diffuse large B‐cell lymphomas is an independent prognostic factor indicating better overall survival

  2004cites this paper
• Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule

  2003cites this paper
• Prognostic value of bcl‐6, CD10 and CD38 immunoreactivity in stage I–II gastric lymphomas: Identification of a subset of CD10+ large B‐cell lymphomas with a favorable outcome

  2003cites this paper
• Immunohistochemical Expression of CD 23 and CD 40 May Identify Prognostically Favorable Subgroups of Diffuse Large B-cell Lymphoma : A Nordic Lymphoma Group Study 1

  2003cites this paper
• Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.

  2003cites this paper
• T-Cell Associated Antigen-Positive B-Cell Lymphoma

  2001cites this paper
• The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma.

  2001cites this paper
• Primary non-Hodgkin's lymphoma of the jaws: immunohistochemical and genetic review of 10 cases.

  2000cites this paper
• Expression of transmembrane 4 superfamily member, CD9, is related to improved progression-free survival in patients with diffuse non-Hodgkin's lymphoma.

  1998cites this paper
• Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders.

  1996cites this paper
• Multiparametric immunophenotyping of B cells in peripheral blood of healthy adults by flow cytometry

  1996cites this paper
• Can prognostic factors be applied in treatment selection for aggressive lymphoma patients?

  1996cites this paper
• Review Article Flow Cytometric Immunophenotyping of Non-Hodgkin's Lymphomas and Related Disorders

  1996cites this paper
• Non-Hodgkin’s Lymphomas

  1995cites this paper
• Prognostic Factors in Aggressive Non-Hodgkin’s Lymphoma

  1995cites this paper
• [The clinicoimmunological characteristics of blast transformation in lymphosarcomas].

  1994cites this paper
• Immunophenotyping of low‐grade B‐cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification

  1993cites this paper
• The usefulness of cell surface markers in predicting the prognosis of non-Hodgkin's lymphomas.

  1993cites this paper
• Prognostic significance of clinical and pathologic features in diffuse large B‐cell lymphoma

  1993cites this paper
• Detection of cancer by tumor markers in the blood: a view to the future.

  1993cites this paper
• References

  1993cites this paper
• DIAGNOSTIC VALUE OF IMMUNOPHENOTYPING IN LOW‐GRADE B‐CELL LYMPHOMA

  1993cites this paper
• Expression of activation antigens CD38 and CD71 is not clinically important in childhood acute lymphoblastic leukemia.

  1993cites this paper
• T-Cell Receptor Vβ-Family Usage in Primary Cutaneous and Primary Nodal T-Cell Non-Hodgkin's Lymphomas

  1992cites this paper
• T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas.

  1992cites this paper
• Immunophenotyping of non-Hodgkin's lymphomas in paraffin-embedded tissue sections. A comparison with genotypic analysis.

  1991cites this paper
• Lymphomas of the mediastinum.

  1991cites this paper
• Distinctive Pattern of Expression of Activation and Resting B Cell Antigens on Normal and Neoplastic Human B Cells: Immunophenotypic Heterogeneity in Some Lymphomas.

  1990cites this paper
• Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.

  1990cites this paper
• A simplified working formulation of non‐Hodgkin's lymphomas based on quantifiable histologic criteria

  1989cites this paper
• Prognostic significance of activation and differentiation antigen expression in B‐cell non‐Hodgkin's lymphoma

  1989cites this paper
• Immunohistochemical evaluation of tumours.

  1989cites this paper